BACKGROUND: Host genetic factors have been suspected to influence histological liver damage in chronic liver disease. The nonsynonymous single-nucleotide polymorphism rs738409 C > G in the patatin-like phospholipase domain-containing 3 gene (PNPLA3, also known as adiponutrin), encoding the I148 M protein variant, has been identified as a novel genetic marker for hepatic steatosis and fibrosis in nonalcoholic fatty liver disease and alcoholic liver disease. We aimed to determine whether the PNPLA3 rs738409 variant was associated with hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. METHODS: In a cross-sectional study in Japan, we analyzed 276 patients with chronic hepatitis C who underwent liver biopsy. Genotyping for rs738409 was performed using the TaqMan genotyping assay. RESULTS: The frequencies of the rs738409 CC, CG, and GG genotypes were 32.6, 46.4, and 21.0 %, respectively. Multivariate analysis revealed that the GG genotype was independently associated with the presence of steatosis [odds ratio (OR) 2.58, 95 % confidence interval (CI) 1.37-4.84, p = 0.003], severe necroinflammatory activity (OR 2.16, 95 % CI 1.12-4.16, p = 0.02), and advanced fibrosis (OR 2.10, 95 % CI 1.07-4.11, p = 0.03), after adjustment for age, sex, body mass index, and diabetes. CONCLUSIONS: The PNPLA3 rs738409 variant influences histological liver damage in Japanese patients with chronic hepatitis C. The G allele homozygotes are at higher risk for hepatic steatosis, severe necroinflammation, and advanced fibrosis.
BACKGROUND: Host genetic factors have been suspected to influence histological liver damage in chronic liver disease. The nonsynonymous single-nucleotide polymorphism rs738409 C > G in the patatin-like phospholipase domain-containing 3 gene (PNPLA3, also known as adiponutrin), encoding the I148 M protein variant, has been identified as a novel genetic marker for hepatic steatosis and fibrosis in nonalcoholic fatty liver disease and alcoholic liver disease. We aimed to determine whether the PNPLA3rs738409 variant was associated with hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. METHODS: In a cross-sectional study in Japan, we analyzed 276 patients with chronic hepatitis C who underwent liver biopsy. Genotyping for rs738409 was performed using the TaqMan genotyping assay. RESULTS: The frequencies of the rs738409 CC, CG, and GG genotypes were 32.6, 46.4, and 21.0 %, respectively. Multivariate analysis revealed that the GG genotype was independently associated with the presence of steatosis [odds ratio (OR) 2.58, 95 % confidence interval (CI) 1.37-4.84, p = 0.003], severe necroinflammatory activity (OR 2.16, 95 % CI 1.12-4.16, p = 0.02), and advanced fibrosis (OR 2.10, 95 % CI 1.07-4.11, p = 0.03), after adjustment for age, sex, body mass index, and diabetes. CONCLUSIONS: The PNPLA3rs738409 variant influences histological liver damage in Japanese patients with chronic hepatitis C. The G allele homozygotes are at higher risk for hepatic steatosis, severe necroinflammation, and advanced fibrosis.
Authors: Andrew C Lake; Ying Sun; Jian-Liang Li; Jae Eun Kim; Jeremy W Johnson; Dongmei Li; Tracy Revett; Heather H Shih; Wei Liu; Janet E Paulsen; Ruth E Gimeno Journal: J Lipid Res Date: 2005-09-08 Impact factor: 5.922
Authors: Yongcheng Huang; Shaoqing He; John Zhong Li; Young-Kyo Seo; Timothy F Osborne; Jonathan C Cohen; Helen H Hobbs Journal: Proc Natl Acad Sci U S A Date: 2010-04-12 Impact factor: 11.205
Authors: Felix Stickel; Stephan Buch; Katharina Lau; Henriette Meyer zu Schwabedissen; Thomas Berg; Monika Ridinger; Marcella Rietschel; Clemens Schafmayer; Felix Braun; Holger Hinrichsen; Rainer Günther; Alexander Arlt; Marcus Seeger; Sebastian Müller; Helmut Karl Seitz; Michael Soyka; Markus Lerch; Frank Lammert; Christoph Sarrazin; Ralf Kubitz; Dieter Häussinger; Claus Hellerbrand; Dieter Bröring; Stefan Schreiber; Falk Kiefer; Rainer Spanagel; Karl Mann; Christian Datz; Michael Krawczak; Norbert Wodarz; Henry Völzke; Jochen Hampe Journal: Hepatology Date: 2010-12-07 Impact factor: 17.425
Authors: Habeeb Salameh; Maen Masadeh; Muhannad Al Hanayneh; Vincent Petros; Matthew Maslonka; Arjun Nanda; Ashwani K Singal Journal: World J Hepatol Date: 2016-12-18
Authors: Rocío Núñez-Torres; Juan Macías; María Mancebo; Mario Frías; Giovanni Dolci; Francisco Téllez; Dolores Merino; Nicolás Merchante; Jesús Gómez-Mateos; Giovanni Guaraldi; Antonio Rivero-Juárez; Juan A Pineda; Luis M Real Journal: PLoS One Date: 2016-12-14 Impact factor: 3.240
Authors: Bernhard Scheiner; Mattias Mandorfer; Philipp Schwabl; Berit Anna Payer; Theresa Bucsics; Simona Bota; Maximilian C Aichelburg; Katharina Grabmeier-Pfistershammer; Albert Stättermayer; Peter Ferenci; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger Journal: PLoS One Date: 2015-11-23 Impact factor: 3.240